We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Ultrasound Characteristics May Eliminate the Need for Some Minimally-Invasive Thyroid Biopsies

By HospiMedica International staff writers
Posted on 22 Jun 2010
Instead of referring patients for ultrasound-guided biopsies, physicians may now be able to rely on specific conventional ultrasound characteristics to determine the pathology of some thyroid nodules, according to recent findings.

"Thyroid nodules affect more than 50% of the population, and statistically more than 85% of them are incidental and benign,” said Barry Sacks, M.D., lead author of the study. More...
"Unfortunately, this means millions of patients are undergoing unnecessary biopsies as doctors are finding a very low number of cancers. This is an enormous cost burden and provokes a lot of unnecessary anxiety for patients,” said Dr. Sacks. "The purpose of our study, performed at MetroWest Medical Center in Natick, MA [USA], and Beth Israel Deaconess Medical Center in Boston, MA [USA], was to determine whether conventional ultrasound alone could predict a specific nodule type--aiding differentiation between benign and malignant thyroid nodules,” he said.

The study findings were presented May 5, 2010, at the American Roentgen Ray Society (ARRS) 2010 annual meeting in San Diego, CA, USA.

"Specifically, we reviewed the accuracy of conventional ultrasound comparing it to the final pathology determined by ultrasound-guided biopsy,” said Dr. Sacks. Of the predicted benign lesions, ultrasound prediction was correct in 89% of the benign cases. Of the lesions that were highly suspicious for malignancy, ultrasound prediction was correct in 94% of the cases. Our data suggest that subsequent triage of some thyroid nodules may be able to be performed solely by ultrasound appearance which will allow us to dramatically reduce the number of unnecessary thyroid nodule biopsies performed,” concluded Dr. Sacks.

Related Links:

MetroWest Medical Center
Beth Israel Deaconess Medical Center



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.